Clinical Trials

454 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07555860 2026-04-29

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

28 enrolled

Nasopharyngeal Carcinoma

NCT07524413 2026-04-13

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

514 enrolled

Nasopharyngeal Neoplasms

NCT07415681 2026-02-17

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

116 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07385079 2026-02-03

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

412 enrolled

Nasopharyngeal Neoplasms

NCT07373990 2026-01-28

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

418 enrolled

Nasopharyngeal Neoplasms

NCT05912582 2025-12-26

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

Not yet recruiting

60 enrolled

Nasopharyngeal Carcinoma

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

164 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

516 enrolled

Phase 1/2 Not yet recruiting

Nasopharyngeal Cancinoma (NPC)

NCT04373785 2025-10-21

NG101m Adjuvant Therapy in Glioblastoma Patients

52 enrolled

CNS

Glioblastoma

NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

408 enrolled

CNSLymphoid

Astrocytoma, Lymphoma, Follicular

NCT06775756 2025-01-15

Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer

474 enrolled

Nasopharyngeal Carcinoma

NCT06578871 2024-09-03

SUPERIOR

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT05791136 2023-03-30

TREE

Phase 2/3 Not yet recruiting

30 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05144100 2021-12-03

SCOPE

498 enrolled

Tumor-Agnostic

Carcinoma

NCT04605562 2021-09-05

Umbrella Biomarker-Guided Therapy in NPC

206 enrolled